Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Shire
  6. Summary
       JE00B2QKY057

SHIRE

 SummaryChartsNewsCompany 
Company
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about SHIRE
2020TAKEDA PHARMACEUTICAL : Drugmaker Takeda expects 35% rise in net profit on lower..
AQ
2020TAKEDA PHARMACEUTICAL : lifts FY 2019 earnings projections after Shire buyout
AQ
2019SHIRE : Annual results
CO
2019SHIRE : Form 8.3 - Takeda Pharmaceutical
PU
2019SHIRE : Form 8.3 -
PU
2019SHIRE : Form 8.5 (EPT/RI) - Replacement of Shire
PU
2019SHIRE : Form 8.5 (EPT/NON-RI)
PU
2019SHIRE : Form 8.5 (EPT/RI)- Shire plc
PU
2019SHIRE : Form 8.5 (EPT/NON-RI)- Shire Plc
PU
2019SHIRE : Form 8.5 - Shire plc
PU
2019SHIRE : Form 8.5 (EPT/RI) - SHIRE PLC
PU
2019SHIRE : Form 8.5 (EPT/RI)
PU
2019SHIRE : Form 8.3 - Takeda Pharmaceutical Company Limited
PU
2019SHIRE : Form 8.3 - Shire PLC
PU
2019SHIRE : Form 8.5 (EPT/RI) - Amendment
PU
More news
News in other languages on SHIRE
2019EN DIRECT DES MARCHES : Nissan, Dassault Aviation, STMicroelectronics, Sika, ..
2019Les affaires reprennent dans la pharmacie
2018Le marché du M&A se prépare à une année 2019 moins faste
2018Les craintes sur les taux et le commerce font plier les actions en Europe
2018Point marchés-Les craintes sur les taux et le commerce font plier les actions..
More news
Analyst Recommendations on SHIRE
More recommendations
Chart SHIRE
Duration : Period :
Shire Technical Analysis Chart | JE00B2QKY057 | MarketScreener
Managers and Directors
Susan O’Reilly Secretary & Director
Anthony Denis Ahern Director
Paul Keogh Director
Anthony Grannell Director
James Dinniss Director
Sector and Competitors
1st jan.Capi. (M$)
SHIRE0.00%0
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604